About US
Contact us
-
2021 forecast: Targeted delivery, oral vaccines and mRNA 2.0: The next generation of drugs and prophylactics in the fight against COVID-19As the chapter closes on the first year of the COVID-19 pandemic, drugmakers are hard at work bolsteringthe defenses mounted in 2020—and they're looking at new formulations and delivery methods to br2020/12/25
-
2021 forecast: M&A poised to rebound in 2021, fueled by pharma's $1.47T in deal-making firepower: analystsWhen AstraZeneca said it would lay out $39 billion for Alexion on Dec. 12—just hours after the first COVID-19 vaccine was approved in the U.S., promising an end to the pandemic—it seemed as good a si2020/12/23
-
2021 forecast: Up for FDA review? Don't hold your breath if COVID-19 continues to delay site inspectionsBringing a therapy to market is a monumental undertaking by any drugmaker, a feat requiring years in the clinic and reams of cash. But when push comes to shove, a drug's commercial hopes must eventua2020/12/23
-
Horizon's Tepezza supply dwindles as manufacturer Catalent pivots to Warp Speed vaccinesHorizon's thyroid eye disease med Tepezza will run scarce from the end of December into 2021, the company said Thursday, blaming COVID-19 vaccine orders that are dominating the agenda at contract man2020/12/21
-
Biogen inks $22M charity kickbacks deal with feds, but argues its conduct was appropriateOver the last few years, the federal government has inked charity kickback settlements with a who’s who of pharma companies. With a new Department of Justice settlement unveiled Thursday, Biogen is j2020/12/21
-
Singapore approves Pfizer and BioNTech’s Covid-19 vaccineSingapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, as well as expects delivery of the first shots by December-end. Singapore is the first Asian country to approve2020/12/18
-
FDA finds Moderna’s Covid-19 vaccine to have no specific safety concernsThe US Food and Drug Administration (FDA) has stated in its briefing document that Moderna’s experimental Covid-19 vaccine, mRNA-1273, is 94.1% effective in preventing symptomatic Covid-19. The U2020/12/18
-
Japan's Kobayashi Kako admits manufacturing mix-up led to patient's deathA "grave" manufacturing error in Japan tainted antifungal tablets with high doses of a sleep medication, leading to the death of one woman in her 70s and side effects in hundreds more people. Kobayas2020/12/17
-
Sanofi promised pandemic hazard pay to vaccine plant workers, then offered 3 days off instead, lawsuit saysAs the pandemic heated up this spring, Sanofi scrambled to make sure its plants would continue to turn out the drugs and vaccines patients needed—and it offered certain workers hazard pay as part of2020/12/17
-
Communication is the strong link in a supply-chain crisisEditorial Note: This article is custom content created in collaboration with AmerisourceBergen. As the COVID-19 crisis began to take hold in the U.S. earlier this year, healthcare systems scrambled t2020/12/16